87.00 -0.08 (-0.09%)
Pre-Market: 8:50AM EDT
|Bid||87.00 x 800|
|Ask||90.00 x 900|
|Day's Range||86.98 - 88.35|
|52 Week Range||76.60 - 110.12|
|PE Ratio (TTM)||20.75|
|Earnings Date||Jul 30, 2018 - Aug 3, 2018|
|Forward Dividend & Yield||2.12 (2.43%)|
|1y Target Est||92.00|
LONDON, UK / ACCESSWIRE / May 23, 2018 / Active-Investors has a free review on The Scotts Miracle-Gro Co. (NYSE: SMG) following the Company's announcement that it will begin trading ex-dividend on May 24, 2018. Active-Investors has initiated due-diligence on this dividend stock. If your portfolio includes dividend stocks, you have come to the right place for timely information.
The Attorney General still won't be able to target states that have legalized medical marijuana. But don't count on a boost for marijuana stocks.
The Scotts Miracle-Gro Company (SMG) received a recent upgrade from a “buy” to a “hold” from SunTrust Robinson Humphrey. The firm also raised its price target to $100 from $80, saying that the stock will likely see an upside when the hydroponics business takes off on the back of increased cannabis use. The stock had terrible first and second quarter results, and the stock is now 19.5% lower YTD (year-to-date) as of May 16.
There’s a growing sense among pundits that the ones selling the "picks and shovels" will be the most consistent winners in the pot gold rush.
WallStEquities.com has initiated research coverage on Monsanto Co. (NYSE: MON), Nutrien Ltd (NTR), The Mosaic Co. (NYSE: MOS), and The Scotts Miracle-Gro Co. (NYSE: SMG). Last Friday at the close, shares in St. Louis, Missouri-based Monsanto Co. ended 0.29% higher at $125.85.
Products related to the marijuana industry account for just 10% of total revenue, yet that's all Wall Street seems to care about these days.
Aphria (APHQF) is also doing its part to penetrate markets where medical cannabis (SEED-TSE) is legal. On May 16, the company signed an exclusive agreement to supply medical cannabis in Columbia. The agreement is with Colcanna SAS, which has the license to import and distribute medical cannabis in the country.
The Fools consider Home Depot’s spring quarter, a tempting way to play the marijuana boom, and the absurdity of wildly overpaid and underperforming CEOs.
Trade Desk, Scotts Miracle-Gro and Cisco Systems highlighted as Zacks Bull and Bear of the Day
Canada is about to become the first major industrialized nation to legalize marijuana use across the country, and the companies that have positioned themselves to profit could see remarkable gains
As Scotts Miracle-Gro (NYSE: SMG ), which develops and sells products for lawn and gardens, prepares to enter its offseason, SunTrust became more optimistic about the company's stock. The Analyst SunTrust ...
The legal cannabis industry is growing at an unprecedented pace. This figure is expected to surge to roughly $35 billion by 2022, GreenWave Advisors managing partner Matt Karnes told Benzinga in a recent conversation. “We expect that by 2022, all states will have implemented either a medical only or fully legal marijuana market,” he said.
Attention dividend hunters! The Scotts Miracle-Gro Company (NYSE:SMG) will be distributing its dividend of $0.53 per share on the 08 June 2018, and will start trading ex-dividend in 8 daysRead More...
SunTrust Robinson Humphrey raises its rating to buy from hold for Scotts Miracle-Gro shares, citing its recent acquisition in the hydroponics space.
It still is too early to mail thank-you notes to the Attorney General, but marijuana investors might want to get them ready.
Want to take advantage of the fast-growing cannabis industry without the high risks of pure-play pot stocks? Then check out these three companies.
Beer, pharmaceutical and tobacco firms are under pressure to retune their business models as support to legalize pot gathers momentum. Nine U.S. states and Washington D.C. now permit their residents to use marijuana without a doctor’s letter, even though federal law still recognizes the drug as illegal. Moody’s expects these developments to have huge implications for investors.
The ongoing legalization of marijuana in US states and its likely nationwide legalization in Canada will affect many of its rated entities, or has already, Moody's Investors Service says in a new report. US state and local governments are collecting sales and excise taxes, as well as licensing fees, on marijuana sales, while the legalization of marijuana represents both a challenge and an opportunity for alcoholic beverage, tobacco, consumer products and pharmaceutical companies. In the US, 29 states have legalized some form of marijuana use, while nine, plus the District of Columbia, allow recreational use, though the drug remains prohibited at the federal level.
In a year so far marked by volatility and uncertainty among some of the old stalwarts of Wall Street, is now the time to consider alternative investments including weed, cryptocurrencies and even gold? According to a panel of experts at TheStreet's Investor Boot Camp conference over the weekend, the answer could very well be yes. If you're investing in a company just because you read a handful of headlines about its foray into legal weed, you're doing it wrong, said Debra Borchardt, co-founder, CEO and editor in chief of the Green Market Report.
Sales growth and gross income growth are also expected to trickle down to Mosaic’s (MOS) EBITDA (earnings before interest, tax, depreciation, and amortization) estimates.
The Scotts Miracle-Gro Company (SMG), the world’s leading marketer of branded consumer lawn and garden products, announced that the Company’s former Chief Financial Officer, David C. Evans, has been named to its Board of Directors. “We are fortunate to have Dave back on our team,” said Jim Hagedorn, chairman and chief executive officer. “Having previously served as CFO at ScottsMiracle-Gro, I have the highest confidence that our shareholders will see benefit from Dave’s strong leadership. Since 2013, Evans served as Executive Vice President and Chief Financial Officer of Battelle Memorial Institute leaving the company in January 2018.
Yesterday, May 2, Scotts Miracle-Gro (SMG) plunged ~8.4% to close the day at $77.5. The company’s earnings were disappointing with sales coming in at $1.0 billion, which missed analyst estimates by 6.4%, while adjusted EPS (earnings per share) came in at $2.88, which also missed the analysts’ estimates by 13%. Read our post-earnings analysis in Scotts Miracle-Gro’s 2Q18 Earnings: What You Need to Know.